{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:27:33Z","timestamp":1762522053727},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12913-017-2410-1","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T11:47:38Z","timestamp":1499255258000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study"],"prefix":"10.1186","volume":"17","author":[{"given":"R.","family":"Boix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fern\u00e1ndez-Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Noguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Larrauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"2410_CR1","volume-title":"Guidelines for the screening, care and treatment of persons with hepatitis C infection","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014."},{"key":"2410_CR2","volume-title":"Hepatitis C surveillance in Europe \u2013 2013","author":"European Centre for Disease Prevention and Control","year":"2015","unstructured":"European Centre for Disease Prevention and Control. Hepatitis C surveillance in Europe \u2013 2013. Stockholm: ECDC; 2015."},{"key":"2410_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13090276","volume":"127","author":"M Bruguera","year":"2006","unstructured":"Bruguera M, Forns X. Hepatitis C in Spain. Med Clin (Barc). 2006;127:113\u20137.","journal-title":"Med Clin (Barc)"},{"key":"2410_CR4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042737-200105000-00003","volume":"13","author":"S Riestra","year":"2001","unstructured":"Riestra S, Fern\u00e1ndez E, Leiva P, Garcia S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol. 2001;13:477\u201381.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2410_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jmv.2091","volume":"65","author":"A Dom\u00ednguez","year":"2001","unstructured":"Dom\u00ednguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia. Spain J Med Virol. 2001;65:688\u201393.","journal-title":"Spain J Med Virol"},{"key":"2410_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0025-7753(02)73328-9","volume":"119","author":"R Sola","year":"2002","unstructured":"Sola R, Cruz de Castro E, Hombrados M, Planas R, Coll S, Jardi R, et al. Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study. Med Clin (Barc). 2002;119:90\u20135.","journal-title":"Med Clin (Barc)"},{"key":"2410_CR7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0213-005X(02)72743-2","volume":"20","author":"MM Chimeno","year":"2002","unstructured":"Chimeno MM, Chocarro A, Brezmes P, Ochoa C, Perez J. Seroprevalence of hepatitis C virus in the general population. Enferm Infecc Microbiol Clin. 2002;20:64\u20137.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2410_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1157\/13102267","volume":"25","author":"R L\u00f3pez-Izquierdo","year":"2007","unstructured":"L\u00f3pez-Izquierdo R, Udaondo MA, Zarzosa P, Garc\u00eda-Ram\u00f3n E, Garcinu\u00f1o S, Bratos MA, et al. Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y Leon (Spain). Enferm Infecc Microbiol Clin. 2007;25:317\u201323.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2410_CR9","first-page":"521","volume":"17","author":"A Gil Miguel","year":"1996","unstructured":"Gil Miguel A, Ruedas A, Santos Santos M, Rey Calero YJ. Prevalence of hepatitis C virus infection in school children in an urban and suburban area of Madrid. Aten Primaria. 1996;17:521\u20132.","journal-title":"Aten Primaria"},{"key":"2410_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1157\/13062888","volume":"27","author":"A Su\u00e1rez Gonz\u00e1lez","year":"2004","unstructured":"Su\u00e1rez Gonz\u00e1lez A, Sol\u00eds S\u00e1nchez G, Otero Guerra L, de la Guerra G V, Navascu\u00e9s C \u00c1, L\u00f3pez R G. The prevalence of markers for the hepatitis a and B viruses in the population of Gij\u00f3n between 6 and 25 years old. Gastroenterol Hepatol. 2004;27:347\u201352.","journal-title":"Gastroenterol Hepatol"},{"key":"2410_CR11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0213-005X(04)73152-3","volume":"22","author":"N Guti\u00e9rrez-Zufiaurre","year":"2004","unstructured":"Guti\u00e9rrez-Zufiaurre N, S\u00e1nchez-Hernandez J, Mu\u00f1oz S, Mar\u00edn R, Delgado N, S\u00e1enz MC, et al. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin. 2004;22:512\u20136.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2410_CR12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ajog.2005.04.045","volume":"193","author":"A Ruiz-Extremera","year":"2005","unstructured":"Ruiz-Extremera A, L\u00f3pez-Garrido MA, Barranco E, Quintero MD, Ocete-Hita E, de Rueda P M, et al. Activity of hepatic enzymes from week sixteen of pregnancy. Am J Obstet Gynecol. 2005;193:2010\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"2410_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4321\/S1130-01082013000500002","volume":"105","author":"JL Calleja Panero","year":"2013","unstructured":"Calleja Panero JL, Llop Herrera E, Ruiz Moraga M, de la Revilla NJ, Calvo Bonacho E, Pons Renedo F, et al. Prevalence of viral hepatitis (band C) serological markers in healthy working population. Rev Esp Enferm Dig. 2013;105:249\u201354.","journal-title":"Rev Esp Enferm Dig"},{"key":"2410_CR14","unstructured":"Ministry of Health, Social Services and Equality. Strategic Plan for tackling Hepatitis C in the Spanish National Health System. Madrid; 2015. http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/docs\/plan_estrategico_hepatitis_C.pdf . Accesed 11 Feb 2016."},{"issue":"Suppl 1","key":"2410_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(Suppl 1):45\u201357.","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"2410_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.12247","volume":"21","author":"P Bruggmann","year":"2014","unstructured":"Bruggmann P, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014;21(Suppl. 1):5\u201333.","journal-title":"J Viral Hepat"},{"key":"2410_CR17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/MEG.0b013e328313139d","volume":"21","author":"A Garc\u00eda-Fulgueiras","year":"2009","unstructured":"Garc\u00eda-Fulgueiras A, Garc\u00eda-Pina R, Morant C, Garc\u00eda-Ortuzar V, G\u00e9nova R, \u00c1lvarez E. Hepatitis C and hepatitis B related mortality in Spain. Eur J Gastroenterol Hepatol. 2009;21:895\u2013901.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2410_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2893.2011.01467.x","volume":"18","author":"A Garc\u00eda-Fulgueiras","year":"2011","unstructured":"Garc\u00eda-Fulgueiras A, Garc\u00eda-Pina C, Morant N, de Larrea-Baz F, \u00c1lvarez E. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem. J Viral Hepat. 2011;18:453\u201360.","journal-title":"J Viral Hepat"},{"key":"2410_CR19","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Informe de hospitalizaci\u00f3n - CMBD \u2013 Registro de altas. Informe resumen 2013. Madrid; 2015. www.msssi.gob.es\/estadEstudios\/estadisticas\/cmbdhome.htm . Accesed 18 Feb 2016."},{"key":"2410_CR20","unstructured":"Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 2014. http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/docs\/CIE9MC_2014_def_accesible.pdf . Accesed 18 Nov 2015."},{"key":"2410_CR21","first-page":"70","volume":"72","author":"MD Esteban-Vasallo","year":"2016","unstructured":"Esteban-Vasallo MD, Dom\u00ednguez-Berj\u00f3n MF, Gil de Miguel \u00c1, Astray-Mochales J, Blanco-Ancos LM, Gil-Prieto R. Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability. J Inf Secur. 2016;72:70\u20139.","journal-title":"J Inf Secur"},{"key":"2410_CR22","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1016\/j.vaccine.2013.05.109","volume":"31","author":"R Gil-Prieto","year":"2013","unstructured":"Gil-Prieto R, Gonzalez-Escalada A, Alvaro-Meca A, Garcia-Garcia L, San-Martin M, Gonz\u00e1lez-L\u00f3pez A, Gil-de-Miguel A. Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirus infections in Spain. Vaccine. 2013;31:5000\u20134.","journal-title":"Vaccine"},{"key":"2410_CR23","first-page":"85","volume":"26","author":"A L\u00f3pez-de-Andr\u00e9s","year":"2013","unstructured":"L\u00f3pez-de-Andr\u00e9s A, Jim\u00e9nez-Garc\u00eda R, Hern\u00e1ndez-Barrera V, Isabel Jim\u00e9nez-Trujillo M, Gil-de-Miguel A, Carrasco-Garrido P. Trends in hospitalizations among children with type 1 diabetes in Spain, 2001-2009. J Pediatr Endocrinol Metab. 2013;26:85\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2410_CR24","unstructured":"Instituto Nacional de Estad\u00edstica. Proyecciones de poblaci\u00f3n. http:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176953&menu=ultiDatos&idp=1254735572981 . Accessed July 2017."},{"key":"2410_CR25","volume-title":"Cancer incidence in five continents","year":"1976","unstructured":"Waterhouse J, Muir CS, Correa P, Powell J, editors. Cancer incidence in five continents. Lyon: IARC Scientific Publications; 1976."},{"key":"2410_CR26","doi-asserted-by":"crossref","unstructured":"Diez M, Garriga C, Pons M, Ten A, Marcos H, Guti\u00e9rrez G, et al. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011. Euro Surveill. 2014; 19 (20): pii=20805.","DOI":"10.2807\/1560-7917.ES2014.19.20.20805"},{"key":"2410_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571\u201383.","journal-title":"Lancet"},{"key":"2410_CR28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S0950268812000921","volume":"141","author":"M Rondy","year":"2013","unstructured":"Rondy M, Wiessing I, Hutchinson SJ, Mathei C, Mathis F, Mravcik V, et al. Hepatitis C prevalence in injecting drug users in Europe, 1990\u20132007: impact of study recruitment setting. Epidemiol Infect. 2013;141:563\u201372.","journal-title":"Epidemiol Infect"},{"key":"2410_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eimc.2014.05.013","volume":"33","author":"M Mart\u00ednez-Rebollar","year":"2015","unstructured":"Mart\u00ednez-Rebollar M, Mallolas J, P\u00e9rez I, Gonz\u00e1lez-Cord\u00f3n A, Lonc\u00e0 M, Torres B, et al. Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients. Enferm Infecc Microbiol Clin. 2015;33:3\u20138.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2410_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2007.07.031","volume":"48","author":"E Mart\u00ednez-Bauer","year":"2008","unstructured":"Mart\u00ednez-Bauer E, Forns X, Armelles M, Planas R, Sol\u00e0 R, Vergara M, et al. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol. 2008;48:20\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"2410_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1157\/13083370","volume":"24","author":"JM Echevarr\u00eda","year":"2006","unstructured":"Echevarr\u00eda JM, Le\u00f3n P, Pozo F, Avell\u00f3n A. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin. 2006;24(1):20\u20135.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Suppl. 1","key":"2410_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","volume":"21","author":"H Razavi","year":"2014","unstructured":"Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today\u2019s treatment paradigm. J Viral Hepat. 2014;21(Suppl. 1):34\u201359.","journal-title":"J Viral Hepat"},{"key":"2410_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvh.12253","volume":"21","author":"GJ Dore","year":"2014","unstructured":"Dore GJ, Ward J, Thursz M. Hepatitis C disease burden and strategies to manage the burden. J Viral Hepat. 2014;21:1\u20134.","journal-title":"J Viral Hepat"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-017-2410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T14:40:26Z","timestamp":1569681626000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-017-2410-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1186\/s12913-017-2410-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]},"article-number":"461"}}